牛唐2019-05-01 17:45
$Cortexyme(CRTX)$ 拥有一个治疗AD的三期药物,背后股东有$辉瑞(PFE)$ 投资、红杉资本、$武田制药(TAK)$ 投资等,早期的数据还是不错的,希望这个AD药物不要再失败了查看全文
美股律师郝俊波2013-02-21 09:42
$科纳斯通医疗(CRTX)$
2013年2月20日该公司(Cornerstone Therapeutics Inc)宣布收到Chiesi Farmaceutici SpA (“Chiesi”).公司的私有化收购要约,每股价格为6.4至6.7美元。我们认为该价格偏低,因为至少有一位分析师认为价格应为14美元。因此我们怀疑该公司董事会涉嫌违法对股东的忠实义务...查看全文
$科纳斯通医疗(CRTX)$ 8-K Current report, item 5.02 Accession Number: 0001193125-22-200068 Act: 34 Size: 178 KB 网页链接
$科纳斯通医疗(CRTX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001422849-22-000154 Act: 34 Size: 18 KB 网页链接
$科纳斯通医疗(CRTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-040306 Size: 9 KB 网页链接
$科纳斯通医疗(CRTX)$ 8-K Current report, items 1.01, 2.03, 5.02, and 5.07 Accession Number: 0001193125-22-172060 Act: 34 Size: 166 KB 网页链接
$科纳斯通医疗(CRTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-035877 Size: 5 KB 网页链接
$科纳斯通医疗(CRTX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-22-035870 Size: 6 KB 网页链接
$科纳斯通医疗(CRTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-035674 Size: 5 KB 网页链接
$科纳斯通医疗(CRTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-035678 Size: 5 KB 网页链接
$科纳斯通医疗(CRTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-035671 Size: 5 KB 网页链接
$科纳斯通医疗(CRTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-035672 Size: 5 KB 网页链接